Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US FDA approves new antibacterial drug Zerbaxa
Zerbaxa is used to treat cUTI, including kidney infection (pyelonephritis)
A Pricey Issue
As part of the ongoing revision of the National List of Essential Medicines (NLEM) 2011, the National Pharma Pricing Authority…
‘India needs to build capacity across the board’
Stephen M Sammut, Senior Fellow, Health Care Management, Wharton School, University of Pennsylvania and Visiting Faculty, Indian…
CCI approves Ranbaxy acquisition by Sun Pharma
Sun Pharma and Ranbaxy had filed the notice with the CCI on May 6, 2014 and sought its approval with respect to the deal
Sigma Aldrich shareholders approve merger with Merck
78 per cent of Sigma-Aldrich shareholders approve transaction
Aurobindo completes the acquisition of Natrol
Aurobindo Pharma announced the completion of acquisition of assets of nutritional supplement maker, Natrol Inc. and other…
Suven Life Sciences raises Rs 200 cr through QIP
The company accordingly will issue 1,04,53,690 equity shares of face value of Rs 1 per equity share at a price of Rs 191.32,…
Bristol Myers Squibb Foundation awards nine grants to India and China
Totalling more than $3.5 million, the grant will support care for high-risk patients with Hepatitis B & C
Pfizer concludes merger with Wyeth
Files order with the Registrar of Companies to conclude the merger process
Zydus launches Adalimuma
Zydus Cadila announced the launch of its biosimilar Adalimumab, following an approval from the Drug Controller General (India)